<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03250455</url>
  </required_header>
  <id_info>
    <org_study_id>CIFuwaiHospital-2</org_study_id>
    <nct_id>NCT03250455</nct_id>
  </id_info>
  <brief_title>Prognostic Value of CT dynamIc Myocardial Perfusion in Patients With Obstructive Coronary Artery Stenosis</brief_title>
  <acronym>VALIDITY</acronym>
  <official_title>Prognostic Value of CT dynamIc Myocardial Perfusion in Patients With Obstructive Coronary Artery Stenosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chinese Academy of Medical Sciences, Fuwai Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Peking Union Medical College Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shanghai Jiao Tong University Affiliated Sixth People’s Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Guangdong General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Tianjin Medical University General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Chinese Academy of Medical Sciences, Fuwai Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      VALIDITY is a prospective, open-label, multicenter, randomized controlled trial
      （ClinicalTrials.gov number）. The study was designed to evaluate the value of noninvasive
      anatomic CTA combined with functional CTP for the next clinical decision making and the added
      prognostic value of CTP beyond CTA.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">August 2017</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">November 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>3 Years</target_duration>
  <primary_outcome>
    <measure>MACE</measure>
    <time_frame>90 days, 6 months, 12 months, 24 months and 36 months</time_frame>
    <description>death, myocardial infarction and unstable angina requiring hospitalization</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>invasive coronary angiography and revascularization</measure>
    <time_frame>90 days, 6 months, 12 months, 24 months and 36 months</time_frame>
    <description>invasive coronary angiography and PCI or CABG</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>he incidence of a composite of major complications from cardiovascular procedures and testing</measure>
    <time_frame>90 days, 6 months, 12 months, 24 months and 36 months</time_frame>
    <description>stroke, bleeding, anaphylaxis, renal failure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life</measure>
    <time_frame>90 days, 6 months, 12 months, 24 months and 36</time_frame>
    <description>Quality of Life (QOL) as Measured by Seattle Angina Scale Anginal Frequency Subscale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>total medical cost</measure>
    <time_frame>90 days and 3 years</time_frame>
    <description>Assess and compare total medical cost for the two diagnostic testing arms by intention to treat</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">1748</enrollment>
  <condition>CT Perfusion</condition>
  <arm_group>
    <arm_group_label>CTA+CTP</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>CTA only</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>CTA CTP</intervention_name>
    <description>CT Angiography myocardial CT Perfusion</description>
    <arm_group_label>CTA+CTP</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>CTA</intervention_name>
    <description>CT Angiography</description>
    <arm_group_label>CTA only</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with stable chest pain and diagnosed of obstructive coronary stenosis (50-90%) by
        CTA were enrolled.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. age ≥18 years.

          2. stable chest pain with obstructive coronary stenosis (50-90%) assessed by CTA.

        Exclusion Criteria:

          -  (1) Diagnosed or suspected acute coronary syndrome (ACS) requiring hospitalization or
             urgent or emergent testing; Elevated troponin or creatine kinase-myocardial band
             (CK-MB).

             (2) Hemodynamically or clinically unstable condition systolic blood pressure (BP) &lt; 90
             mmHg, atrial or ventricular arrhythmias, or persistent resting chest pain felt to be
             ischemic despite adequate therapy.

             (3) Known CAD with prior Myocardial infarction (MI), percutaneous coronary
             intervention (PCI), coronary artery bypass graft (CABG).

             (4) Known significant congenital, valvular (&gt; moderate) or cardiomyopathic process
             (hypertrophic cardiomyopathy or reduced systolic left ventricular function (LVEF) ≤
             40%)) which could explain cardiac symptoms.

             (5) Contraindication to undergoing CTA, including but not limited to: a. Allergy to
             iodinated contrast agent, b. Unable to receive beta blockers, c. creatinine ≥1.7 mg/dl
             or GFR≤30 ml/min , d. Pregnancy.

             (6) Contraindication to ATP, including but not limited to: a. II or III
             atrioventricular block, b. bronchial asthma, c. hypotension (SBP&lt;90mmHg), d. bronchial
             stenosis or bronchospasm, e. acute myocardial infarction, f. left main stenosis, g.
             unstable angina, h. allergy to aminophylline.

             (7) Life expectancy &lt; 2 years. (8) Unable to provide written informed consent or
             participate in long-term follow-up.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Bin Lu, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fuwai Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yang Gao, MD</last_name>
    <phone>86-10-88328651</phone>
    <email>gaoyang226@126.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Fuwai Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100037</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bin Lu, MD</last_name>
      <phone>86-10-88322662</phone>
      <email>blu@vip.sina.com</email>
    </contact>
    <contact_backup>
      <last_name>Yang Gao, MD</last_name>
      <phone>86-10-88322651</phone>
      <email>gaoyang226@126.com</email>
    </contact_backup>
    <investigator>
      <last_name>Bin Lu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yang Gao, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Xiehe Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yingning Wang, MD</last_name>
      <phone>86-10-13661003076</phone>
      <email>yiningpumc@163.com</email>
    </contact>
    <contact_backup>
      <last_name>Lu Lin, MD</last_name>
      <phone>86-10-13520298919</phone>
      <email>linlu03@sina.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Guangdong General Hospital</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510080</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Hui Liu, MD</last_name>
      <phone>8613580352002</phone>
      <email>13580352002@139.com</email>
    </contact>
    <contact_backup>
      <last_name>Hui Gu, MD</last_name>
      <phone>86-0531-68776770</phone>
      <email>18201287661@126.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Shanghai Sixth People's Hospital</name>
      <address>
        <city>Shanghai</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jiayin Zhang, MD</last_name>
      <phone>86-20-18930173280</phone>
      <email>andrewssmu@msn.com</email>
    </contact>
    <contact_backup>
      <last_name>Jian Ma, MD</last_name>
      <phone>86-20-18930174762</phone>
      <email>drmajian@126.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>General hospital of tianjin medical university</name>
      <address>
        <city>Tianjin</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Zhang Zhang, MD</last_name>
      <phone>15900388839</phone>
      <email>filea1249@sina.com</email>
    </contact>
    <contact_backup>
      <last_name>Dong Li, MD</last_name>
      <phone>15222709990</phone>
      <email>dr_lidong@163.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 10, 2017</study_first_submitted>
  <study_first_submitted_qc>August 10, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 15, 2017</study_first_posted>
  <last_update_submitted>August 10, 2017</last_update_submitted>
  <last_update_submitted_qc>August 10, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 15, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chinese Academy of Medical Sciences, Fuwai Hospital</investigator_affiliation>
    <investigator_full_name>Bin Lu</investigator_full_name>
    <investigator_title>chief of Radilogy</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Stenosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

